Fulvestrant, a hormone therapy, is one of two SERDs approved to treat metastatic breast cancer in those who are postmenopausal. It’s an injection that can be used alone or in combination with other drugs.
Support research with a legacy gift. Sample, non-binding bequest language:
I give to the Breast Cancer Research Foundation, located in New York, NY, federal tax identification number 13-3727250, ________% of my total estate (or $_____).
Stay in the know with the latest research news, insights, and resources delivered to your inbox.
Follow BCRF on all the major platforms for research news, inspiring stories, and more.
